- Home
- CRDF vs PZC Comparison
CRDF vs PZC Comparison
Compare CRDF & PZC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- PZC
- Stock Information
- Founded
- CRDF 1999
- PZC 2002
- Country
- CRDF United States
- PZC United States
- Employees
- CRDF N/A
- PZC N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- PZC Investment Managers
- Sector
- CRDF Health Care
- PZC Finance
- Exchange
- CRDF Nasdaq
- PZC Nasdaq
- Market Cap
- CRDF 143.4M
- PZC 168.0M
- IPO Year
- CRDF N/A
- PZC N/A
- Fundamental
- Price
- CRDF $2.58
- PZC $7.09
- Analyst Decision
- CRDF Strong Buy
- PZC
- Analyst Count
- CRDF 3
- PZC 0
- Target Price
- CRDF $9.33
- PZC N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- PZC 48.2K
- Earning Date
- CRDF 11-07-2024
- PZC 01-01-0001
- Dividend Yield
- CRDF N/A
- PZC 4.68%
- EPS Growth
- CRDF N/A
- PZC N/A
- EPS
- CRDF N/A
- PZC N/A
- Revenue
- CRDF $688,000.00
- PZC N/A
- Revenue This Year
- CRDF $15.00
- PZC N/A
- Revenue Next Year
- CRDF N/A
- PZC N/A
- P/E Ratio
- CRDF N/A
- PZC N/A
- Revenue Growth
- CRDF 49.57
- PZC N/A
- 52 Week Low
- CRDF $1.07
- PZC $6.30
- 52 Week High
- CRDF $6.42
- PZC $8.20
- Technical
- Relative Strength Index (RSI)
- CRDF 41.24
- PZC 33.84
- Support Level
- CRDF $2.85
- PZC $7.11
- Resistance Level
- CRDF $4.38
- PZC $7.24
- Average True Range (ATR)
- CRDF 0.45
- PZC 0.07
- MACD
- CRDF -0.10
- PZC -0.01
- Stochastic Oscillator
- CRDF 2.70
- PZC 3.45
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About PZC PIMCO California Municipal Income Fund III of Beneficial Interest
PIMCO CA Muni Income Fund III operates as a closed-end management investment company. The investment objective of the fund is to seek to provide current income exempt from federal and California income tax. Its portfolio of investments includes investment in different sectors such as education, healthcare, industrial and others.